Financhill
Back

Surgepays Quote, Financials, Valuation and Earnings

Surgepays Price Quote

$1.70
+0.03 (+1.8%)
(Updated: November 12, 2024 at 5:55 PM ET)

Surgepays Key Stats

Buy
54
Surgepays (SURG) is a Buy

Day range:
$1.52 - $1.70
52-week range:
$1.33 - $9.23
Dividend yield:
0%
P/E ratio:
1.21
P/S ratio:
0.25
P/B ratio:
0.71%

Volume:
173.7K
Avg. volume:
140.2K
1-year change:
-67.82%
Market cap:
$33M
Revenue:
$137.1M
EPS:
$0.09

How Much Does Surgepays Make?

  • How Much Are Surgepays's Sales Annually?
    SURG Revenues are $137.1M
  • How Much Profit Does Surgepays's Make A Year?
    SURG net income is $20.6M

Is Surgepays Growing As A Company?

  • What Is Surgepays's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.58%
  • What Is Surgepays's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Surgepays Stock Price Performance

  • Did Surgepays Stock Go Up Last Month?
    Surgepays share price went down by -18.54% last month
  • Did SURG's Share Price Rise Over The Last Year?
    SURG share price fell by -67.82% over the past 1 year

What Is Surgepays 52-Week High & Low?

  • What Is Surgepays’s 52-Week High Share Price?
    Surgepays has traded as high as $9.23 over the past 52 weeks
  • What Is Surgepays’s 52-Week Low Share Price?
    Surgepays has traded as low as $1.33 over the past 52 weeks

Surgepays Price To Free Cash Flow

Is It Risky To Buy Surgepays?

  • How Much Debt Does Surgepays Have?
    Total long term debt quarterly is $4.8M
  • How Much Cash Does Surgepays Have?
    Cash and short term investments quarterly total is $38.4M
  • What Is Surgepays’s Book Value Per Share?
    Book value per share is 2.38

Is Surgepays Cash Flow Positive?

  • What Is SURG Cash Flow From Operations?
    Cash flow from operations (TTM) is $10M
  • What Is Surgepays’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $23.3M
  • What Is Surgepays’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Surgepays Return On Invested Capital

  • Is Management Doing A Good Job?
    SURG return on invested capital is -3.9%
  • What Is Surgepays Return On Assets?
    ROA measures how assets are converting to revenues and is -3.06%
  • What Is SURG Return On Equity?
    ROE is a measure of profitability and is -4.48%

Surgepays Earnings Date & Stock Price

  • What Is Surgepays's Stock Price Today?
    A single share of SURG can be purchased today for 1.67
  • What Is Surgepays’s Stock Symbol?
    Surgepays trades on the nasdaq under the ticker symbol: SURG
  • When Is Surgepays’s Next Earnings Date?
    The next quarterly earnings date for Surgepays is scheduled on November 12, 2024
  • When Is SURG's next ex-dividend date?
    Surgepays's next ex-dividend date is November 13, 2024
  • How To Buy Surgepays Stock?
    You can buy Surgepays shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Surgepays Competitors

  • Who Are Surgepays's Competitors?
    Below is a list of companies who compete with Surgepays or are related in some way:
    • Automatic Data Processing Inc (ADP)
    • Autodesk Inc (ADSK)
    • Agilysys Inc (AGYS)
    • Inuvo Inc (INUV)
    • Issuer Direct Corp (ISDR)

Surgepays Dividend Yield

  • What Is SURG Dividend Yield?
    Surgepays’s dividend yield currently is 0%
  • What Is Surgepays’s Payout Ratio?
    Surgepays’s payout ratio is 0%
  • When Did Surgepays Last Pay A Dividend?
    The latest dividend pay date is November 13, 2024
  • What Is Surgepays’s Dividend Per Share?
    Surgepays pays a dividend of $0.00 per share

Surgepays Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -826.53%
Revenue: -57.96% -0.45%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 5.50
Upside from Last Price: 229.34%

Major Shareholders

  • How many SURG shares are owned by institutional investors?
    2.4M SURG shares are owned by institutional investors
  • How many SURG shares are owned by insiders?
    8M SURG shares are owned by insiders